Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:02 07/07/2026 BST			5-day change	1st Jan Change
228.68 ^USD	-1.19%		+0.83%	+14.64%

07-07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	11.15B		AA
LONZA GROUP AG	50.25B		AAA
REVOLUTION MEDICINES, INC.	40.39B	-	B	-	-
IQVIA HOLDINGS INC.	34.38B		AAA
BEONE MEDICINES AG	34.4B		-
CELLTRION, INC.	26.32B		A
ASCENDIS PHARMA A/S	16.64B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.14B		BBB
EUROFINS SCIENTIFIC SE	13.71B		AA
IONIS PHARMACEUTICALS, INC.	13.75B	-	A	-	-
ABIVAX	12.69B	-	BBB	-	-
ICON PUBLIC LIMITED COMPANY	13.09B		AAA
BIO-TECHNE CORPORATION	11.05B		AA
TEMPUS AI, INC.	10.9B		A		-
APOGEE THERAPEUTICS, INC.	10.01B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.44B	-	BBB	-	-
ALKERMES PLC	9.19B		A
PRAXIS PRECISION MEDICINES, INC.	8.74B	-	B	-	-
PROTAGONIST THERAPEUTICS, INC.	8.46B		BB		-
QIAGEN N.V.	8.1B		AAA
Average	17.94B		A
Weighted average by Cap.			A